Table 2.
| Source | Receptors class/target cells | Functions | Clinical applications in orthopaedics | |
|---|---|---|---|---|
| BMPs | Osteoprogenitor cells, osteoblasts, bone extracellular matrix | Serine/threonine kinase receptors, stem cell and chondrocyte | Promotes differentiation of mesenchymal stem cells/ osteoprogenitor cells into chondrocytes and osteoblasts, influences skeletal pattern formation | rhBMP-2 is used for the treatment of anterior lumbar spinal fusion and open tibial fractures, and rhBMP-7 is used for posterolateral lumbar spine fusion |
| FGFs | Macrophage, mesenchymal cells, chondrocytes, osteoblasts | Tyrosine kinase receptors | Mitogenic for mesenchymal stem cells, chondrocytes, and osteoblasts. Increases collagen deposition and angiogenesis [57] |
|
| VEGF | Platelets, chondrocytes in callus | Vascular endothelial cells | Increases angiogenesis and vascular development | |
| PTH | Parathyroid glands | Stem cell, chondrocyte and osteoblast | Increased callus size, bone mass and mineral content | The full length PTH(1–84) and a segment, PTH(1–34), is used to increase the cancellous bone mass and reduce the risk of vertebral and non-vertebral fracture of patients with osteoporosis |
| PRP | blood | Variety cell types | Cocktail of growth factors | Mainly applied in orthopaedics and sports medicine to help hemostasis and musculoskeletal healing [184] |
Abbreviations: BMPs, bone morphogenetic proteins; FGFs, fibroblast growth factors; VEGF, vascular endothelial growth factor; (rh)PTH, (recombinant human)parathyroid hormone; PRP, platelet-rich plasma.